Second generation medical traction therapy device indicated for Peyronie's disease.
Prospective, randomized (control group) clinical studies with RestoreX™ as the sole treatment.
Effective traction therapy to straighten the penis and recover lost length.
RestoreX™ is the only traction therapy treatment for Peyronie's disease with dual force :
1) An axial traction to align the penis.
2) An angular force to counteract penile curvature.
These two actions are designed to soften the localized fibrotic plaque in the tunica albuginea in order to restore
the penis’s straightness and length.
Unlike other single-stretch traction therapy systems that require between 3 and 9 hours of daily use, RestoreX™ is effective with one or two daily sessions lasting 30 to 60 minutes for 12 weeks ¹,.
²ᵃUsing RestoreX™ can complement other treatments prescribed by your urologist.
Speed
Daily session of 30 to 60 minutes.
Simplicity
Easy positioning on the penis in 30 seconds.
Safety
Traction therapy is very physiological, a non-invasive treatment without surgery or medication.
Efficiency
Prospective randomized clinical studies (with a control group).
RestoreX™ can be used very easily in the privacy of your home; it is a very physiological treatment for Peyronie's disease, without drugs, scalpels or injections.
Significant reduction in curvature
77% of patients observed a reduction in the curvature of their penis. The average reduction was 17°, or 28% compared to the initial curvature. One in two men, or 48% of the 77% who experienced a reduction, saw a decrease in curvature of more than 20°.
Length recovery
94% of patients regained the lost length. Average lengthening of 1.6 cm, or 11% more compared to the measurement taken at the start of therapy.
Improvement of erectile function
73% of patients experienced an improvement in their erectile function.
The patients' preferred solution
100% of patients preferred RestoreX™ to other traction therapy devices.
No complications
No adverse or side effects were recorded during treatment with RestoreX™.